Anticholinergic therapy for chronic asthma in children over two years of age

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 6, 2003, Pages

  McDonald, Nicola ^a   Bara, Anna ^b   McKean, Michael C ^c  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b Medical Unit   (United Kingdom)

^c NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT;

ASTHMA; CHILD; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; META ANALYSIS; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; CHILD, PRESCHOOL; CHOLINERGIC ANTAGONISTS; CHRONIC DISEASE; HUMANS; RANDOMIZED CONTROLLED TRIALS;

EID: 0141724771     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003535     Document Type: Review

References (129)

1. Bratteby LE, Foucard T, Lonnerholm G. Combined treatment with ipratropium bromide and beta-2-adrenoceptor agonists in childhood asthma. European Journal of Respiratory Diseases 1986;68(4):239-47.
2. Freeman J, Landau LI. The effects of ipratropium bromide and fenoterol nebulizer solutions in children with asthma. Clinical Pediatrics 1989;28(12):556-60.
3. Hutchison AA, Olinsky A, Landau LI. Long term atropine in chronic severe childhood asthma. Australian Paediatric Journal 1980;16(4):267-9.
4. Mann NP, Hiller EJ. Ipratropium bromide in children with asthma. Thorax 1982;37(1):72-4.
5. Raes M, Mulder P, Kerrebijn KF. Long-term effect of ipratropium bromide and fenoterol on the bronchial hyperresponsiveness to histamine in children with asthma. Journal of Allergy & Clinical Immunology 1989;84(6 (Pt 1)):874-9.
6. Sly PD, Landau LI. Ipratropium bromide does not diminish the diurnal variation of asthma in children. Australian and New Zealand Journal of Medicine - Supplement. 1985;15(4):496.
7. Sly PD, Landau LI, Olinsky A. Failure of ipratropium bromide to modify the diurnal variation of asthma in asthmatic children. Thorax 1987;42(5):357-60.
8. Vazquez C, Fidalgo I, Virto MC, Labayru MT, Casas C. Effectiveness of disodium cromoglycate, salbutamol, and ipratropium bromide in the inhibition of exercise-induced bronchospasm. Anales Espanoles De Pediatria 1984;20(8):756-62.
9. Zimmermann T, Drexel W. Bronchial asthma in childhood. Therapy with fenoterol and ipratropium bromide powder. Monatsschr Kinderheilkd 1984;132(12):915-7.
10. Agostini M, Barlocco G, Mastella G. Protection against exercise induced asthma in children. Double blind controlled clinical trial with fenoterol spray, fenoterol plus ipratropium and oral clenbuterol. Rivista Italiana di Pediatrica 1983;9(4):347-52.
11. Agostini M, Barlocco G, Mastella G. Protective effect of fenoterol spray, ipratropium bromide plus fenoterol spray, and oral clenbuterol, on exercise-induced asthma in children. Double blind controlled and randomized clinical trial. European Journal of Respiratory Diseases - Supplement 1983;128(Pt 2):529-32.
12. Alanko K, Poppius H. Anticholinergic blocking of prostaglandin-induced bronchoconstriction. British Medical Journal 1973;1(848):294.
13. Allen HD, Mellis CM. Reproducibility and blocking studies with metabisulphite. Australian and New Zealand Journal of Medicine - Supplement 1985;15(4):497.
14. Bach-Mortensen N, Bundgaard A, Schmidt A. Ipratropium (Atrovent) treatment - alone and in combination - in children with exercise-induced asthma. Postgraduate Medical Journal 1987;63(Suppl 1):11a.
15. Bandouvakis J, Cartier A, Roberts R, Ryan G, Hargreave FE. The effect of ipratropium and fenoterol on methacholine-histamine-induced bronchoconstriction. British Journal of Diseases of the Chest 1981;75(3):295-305.
16. Beck R, Robertson C, Galdes-Sebaldt M, Levison H. Combined salbutamol and ipratropium bromide by inhalation in the treatment of severe acute asthma. Journal of Pediatrics 1985;107(4):605-8.
17. Benito Fernandez J, Mintegui Raso S, Sanchez Echaniz J, Vazquez Ronco MA, Pijoan Zubizarreta JI. Efficacy of early administration of nebulized ipratropium bromide in children with acute asthma attack. Anales Espanoles de Pediatria 2002;53(3):217-222.
18. Boner AL, Zamo CR, Marchiori MM, Biancotto R, Antolini I, Vallone G. Comparison of nebulized ipratropium, salbutamol and cromoglicate solutions, cromoglicate inhaled powder, theophylline elixir and placebo in exercise induced asthma of the children [Confronto fra nebulizzazione di ipratropio, salbutamolo e cromoglicato in soluzione, cromoglicato in polvere inalabile, teofillina elisir e placebo nell'asma da esercizio dei bambini]. Italian Journal of Chest Diseases (Giornale Italiano Malattie del Torace) 1984;38(6):395-9.
19. Boner AL, De Stefano G, Niero E, Vallone G, Gaburro D. Salbutamol and ipratropium bromide solution in the treatment of bronchospasm in asthmatic children. Annals of Allergy 1987;58(1):54-8.
20. Boner AL, Antolini I, Andreoli A, De Stefano G, Sette L. Comparison of the effects of inhaled calcium antagonist verapamil, sodium cromoglycate and ipratropium bromide on exercise-induced bronchoconstriction in children with asthma. European Journal of Pediatrics 1987;146(4):408-11.
21. Borut TC, Tashkin DP, Fischer TJ, Katz R, Rachelefsky G, Siegel SC, Lee E, Harper C. Comparison of aerosolized atropine sulfate and SCH 1000 on exercise-induced bronchospasm in children. Journal of Allergy and Clinical Immunology 1977;60(2):127-33.
22. Caubet Y. Efficacy, safety and preference of bronchodilator aerosol-dosers in older asthmatic children [Efficacite tolerance et preference chez le grand enfant des aerosols doseurs de bronchodilatateurs]. La Revue de Pediatrie 1988;24(5):215-21.
23. Chen WY, Brenner AM, Weiser PC, Chai H. Atropine and exercise-induced bronchoconstriction. Chest 1981;79(6):651-6.
24. Chervinsky P. Double-blind study of ipratropium bromide, a new anticholinergic bronchodilator. Journal of Allergy & Clinical Immunology 1977;59(1):22-30.
25. Clarke PS, Jarrett RG, Hall GJ. The protective effect of ipratropium bromide aerosol against bronchospasm induced by hyperventilation and the inhalation of allergen, methacholine and histamine. Annals of Allergy 1982;48(3):180-3.
26. Cook JJ, Fergusson DM, Dawson KP. Ipratropium and fenoterol in the treatment of acute asthma. Pharmatherapeutica 1985;4(6):383-6.
27. Coulthard K, Lines D, Rossi S, Cressi N. Inhaled ipratropium bromide (atrovent) in asthmatic children. Australian Journal of Hospital Pharmacy 1985;Suppl:52.
28. Craven D, Kercsmar CM, Myers TR, O'Riordan MA, Golonka G, Moore S. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. Journal of Pediatrics 2001;138(1):51-8.
29. Crimi N, Palermo F, Ciccarello C, Distefano SM, Vancheri C, Cacopardo B, Mistretta A. Effect of Duovent (ipratropium bromide and fenoterol) on non-specific bronchial hyperreactivity. Respiration 1986;50(Suppl 2):206-8.
30. Crimi N, Palermo F, Oliveri R, Polosa R, Settinieri I, Mistretta A. Protective effects of inhaled ipratropium bromide on bronchoconstriction induced by adenosine and methacholine in asthma. European Respiratory Journal 1992;5(5):560-5.
31. Cropp GJA. The role of the parasythmpathetic nervous system in the maintenance of chronic airway obstruction in asthmatic children. American Review of Respiratory Disease 1975;112(5):599-605.
32. Davis A, Vickerson F, Worsley G, Mindorff C, Kazim F, Levison H. Determination of dose-response relationship for nebulized ipratropium in asthmatic children. Journal of Pediatrics 1984;105(6):1002-5.
33. DeStefano G, Bonetti S, Bonizzato C, Valletta EA, Piacentini GL, Boner AL. Additive effect of albuterol and ipratropium bromide in the treatment of bronchospasm in children. Annals of Allergy 1990;65(4):260-2.
34. Ducharme FM, Davis GM. Randomized controlled trial of ipratropium bromide and frequent low doses of salbutamol in the management of mild and moderate acute pediatric asthma. Journal of Pediatrics 1998;133(4):479-85.
35. Dutt NS, Reddy TC, Raghuveer TS, Yeshwanth M, Sunil Dutt N, Chinnapa Reddy T, et al. A comparative study of atropine sulphate, terbutaline and their combination in asthmatic children. Lung India 1990;8(2):73-5.
36. Filiz A, Ekinci E, Dikensoy O, Bulgur D, Oz M. Comparison of a single dose of aerosol salbutamol and fenoterol/ipratropium on bronchial asthmatic patients. Delaware Medical Journal 1994;66(10):549-52.
37. Friberg S, Graff-Lonnevig V. Ipratropium bromide (Atrovent) in childhood asthma: a cumulative dose-response study. Annals of Allergy 1989;62(2):131-4.
38. Godfrey S, Konig P. Suppression of exercise-induced asthma by salbutamol, theophylline, atropine, cromolyn, and placebo in a group of asthmatic children. Pediatrics 1975;56(5 pt-2 Suppl):930-4.
39. Godfrey S, Konig P. Inhibition of exercise induced asthma by different pharmacological pathways. Thorax 1976;31(2):137-43.
40. Greenough A, Yuksel B, Everett L, Price JF. Inhaled ipratropium bromide and terbutaline in asthmatic children. Respiratory Medicine 1993;87(2):111-4.
41. Groggins RC, Milner AD, Stokes GM. Bronchodilator effects of clemastine, ipratropium, bromide, and salbutamol in preschool children with asthma. Archives of Disease in Childhood 1981;56(5):342-4.
42. Groot CA, Lammers JW, Festen J, van Herwaarden CL. The protective effects of ipratropium bromide and terbutaline on distilled water-induced bronchoconstriction. Pulmonary Pharmacology 1994;7(1):59-63.
43. Gross NJ. Sch 1000: a new anticholinergic bronchodilator. American Review of Respiratory Disease 1975;112(6):823-8.
44. Guill MF, Maloney MJ, DuRant RH. Comparison of inhaled metaproterenol, inhaled atropine sulfate, and their combination in treatment of children with acute asthma. Annals of Allergy 1987;59(5):367-71.
45. Hemstreet MP. Atropine nebulization--simple and safe. Annals of Allergy 1980;44(3):138-41.
46. Henry RL, Hankin RG, Abramson R. Comparison of preservative-free and preservative-containing ipratropium bromide. Australian Paediatric Journal 1989;25(2):86-8.
47. Hodges IGC, Groggins RC, Milner AD, Stokes GM. Bronchodilator effect of inhaled ipratropium bromide in wheezy toddlers. Archives of Disease in Childhood 1981;56(9):729-32.
48. Jedrys U, Kurzawa R, Haluszka J, Smieszek J, Doniec Z, Willim G. Evaluation of the bronchodilatory activity of berodual and its components: fenoterol and ipratropium bromide in children with bronchial asthma. Pneumonologia I Alergologia Polska 1994;62(11-12):615-22.
49. Kishida M, Sasamoto A, Saito S, Iikura Y. Oxatomide modifies methacholine- and exercise-induced bronchoconstriction in asthmatic children. Annals of Allergy 1992;69(5):455-61.
50. Krasnowska M, Jankowska R, Jagiello E. The effect of inhaling pirenzepine--selective M1 receptor antagonist and ipratropium bromide on lung ventilation in patients with bronchial asthma. Pneumonologia i Alergologia Polska 1994;62(11-12):609-14.
51. Krasnowska M, Fal AM, Jagiello E. Effect of inhaled pirenzepine and ipratropium bromide on ventilation parameters in patients with asthma. International Review of Allergology & Clinical Immunology 2004;10(1):18-21.
52. Kreisman H, Cohen C, Ghezzo H, Vickerson F, Frank H, Wolkove N. Combined therapy with ipratropium and theophylline in asthma. Annals of Allergy 1984;52(2):90-3.
53. Larsson K. Ipratropium bromide: bronchodilator action and effect on methacholine-induced bronchoconstriction. Journal of Asthma 1987;24(1):29-35.
54. Lefcoe NM, Toogood JH, Blennerhassett G, Baskerville J, Paterson NA. The addition of an aerosol anticholinergic to an oral beta agonist plus theophylline in asthma and bronchitis. A double-blind single dose study. Chest 1982;82(3):300-5.
55. Lenney W, Evans NA. Nebulized salbutamol and ipratropium bromide in asthmatic children. British Journal of Diseases of the Chest 1986;80(1):59-65.
56. Lew DB, Herrod HG, Crawford LV. Combination of atropine and isoetharine aerosol therapy in pediatric acute asthma. Annals of Allergy 1990;64(2 Pt 2):195-200.
57. Li SF, Yao WJ. Combined application of salbutamol and ipratropium bromide in the treatment of bronchial asthma in children. Herald of Medicine 2003;22(2):96-7.
58. Lightbody IM, Ingram CG, Legge JS, Johnston RN. Ipratropium bromide, salbutamol and prednisolone in bronchial asthma and chronic bronchitis. British Journal of Diseases of the Chest 1978;72(3):181-6.
59. Lin MT, Lee-Hong E, Collins-Williams C. A clinical trial of the bronchodilator effect of Sch 1000 aerosol in asthmatic children. Annals of Allergy 1978;40(5):326-32.
60. Lines DR, Coulthard KP. Inhaled Ipratropium Bromide (atrovent) in asthmatic children. Australian Paediatric Journal 1983;19(2):128.
61. Mannino F, Anticoli S, De Luca A, Terzano C. Time course of methacholine induced bronchoconstriction during drugs and spontaneous resolution. Allergologia Et Immunopathologia 1996;24(2):70-4.
62. Mazzei JA, Torres J. Blind randomized cross-over comparative study of salbutamol and the combination fenoterol-ipratropium IK6 in patients with bronchial asthma. Respiration 1986;50(Suppl 2):313-7.
63. McNeill RS, Nairn JR, Millar JS, Ingram CG. Exercise-induced asthma. Quarterly Journal of Medicine 1966;35(137):55-67.
64. Miraglia Del Giudice M, Maiello N, Capristo AF, Caputo A, Pinto F. Short and medium-term controlled study of the bronchodilating effects of a fenoterol-ipratropium bromide combination in asthmatic children. Archivio Monaldi Per La Tisiologia e Le Malattie Dell'Apparato Respiratorio 1983;38(5-6):279-94.
65. Muranyi L, Szekeres I, Butor E. Pharmacocapnography, a clinical pharmacological method based on analysis of the CO2-curve for the pharmacodynamic study of bronchial reactivity. Action of atropine on acetylcholine--induced bronchoconstriction in asthmatic children. International Journal of Clinical Pharmacology, Therapy & Toxicology 1974;9(2):93-7.
66. Neijens HJ, Wesselius TR, Kerrebijn KF. Effect of drugs on effort dyspnoea in children with severe CARA. Nederlands Tijdschrift voor Geneeskunde 1981;125(32):1277-81.
67. Neild JE, Cameron IR. Bronchoconstriction in response to suggestion: its prevention by an inhaled anticholinergic agent. British Medical Journal Clinical Research Edition 1985;290(6469):674.
68. Pasterkamp H, Tal A, Leahy F, Fenton R, Chernick V. The effect of anticholinergic treatment on postexertional wheezing in asthma studied by phonopneumography and spirometry. American Review of Respiratory Disease 1985;132(1):16-21.
69. Pauwels JH, van Bever HP, Desager KN, Creton W, Van der Veken J. Dose-response curve of oxitropium bromide (OB) in preschool asthmatics [abstract]. European Respiratory Journal 1995;19(Suppl 8):517s.
70. Peters JI, Shelledy DC, Jones AP Jr, Lawson RW, Davis CP, LeGrand TS. A randomized, placebo-controlled study to evaluate the role of salmeterol in the in-hospital management of asthma. Chest 2000;118(2):313-20.
71. Poppius H, Salorinne Y. Comparative trial of salbutamol and an anticholinergic drug, SCH 1000, in prevention of exercise-induced asthma. Scandinavian Journal of Respiratory Diseases 1973;54(3):142-7.
72. Rachelefsky GS, Tashkin DP, Katz RM, Kershnar H, Siegel SC. A comparison of aerosolized atropine, isoproterenol, atropine plus isoproterenol, disodium cromoglycate and placebo in the prevention of exercise-induced asthma. Chest 1978;73(6 Suppl):1017-9.
73. Rayner RJ, Cartlidge PH, Upton CJ. Salbutamol and ipratropium in acute asthma. Archives of Disease in Childhood 1987;62(8):840-1.
74. Ream RS, Loftis LL, Albers GM, Becker BA. Efficacy of IV theophylline in children with severe status asthmaticus. Chest 2001;119(5):1480-8.
75. Rebuck AS, Gent M, Chapman KR. Anticholinergic and sympathomimetic combination therapy of asthma. Journal of Allergy & Clinical Immunology 1983;71(3):317-23.
76. Reisman J, Galdes-Sebalt M, Kazim F, Canny G, Levison H. Frequent administration by inhalation of salbutamol and ipratropium bromide in the initial management of severe acute asthma in children. Journal of Allergy & Clinical Immunology 1988;81(1):16-20.
77. Russo GH, Bellia CA, Bodas AW. Exercise-induced asthma (EIA): its prevention with the combined use of ipratropium bromide and fenoterol. Respiration 1986;50(Suppl 2):258-61.
78. Sanguinetti CM, De Luca S, Gasparini S, Massei V. Evaluation of Duovent in the prevention of exercise-induced asthma. Respiration 1986;50(Suppl 2):181-5.
79. Schlueter DP, Neumann JL. Double blind comparison of acute bronchial and ventilation-perfusion changes to atrovent and isoproterenol. Chest 1978;73(6 Suppl):982-3.
80. Schuh S, Johnson DW, Callahan S, Canny G, Levison H. Efficacy of frequent nebulized ipratropium bromide added to frequent high-dose albuterol therapy in severe childhood asthma. Journal of Pediatrics 1995;126(4):639-45.
81. Sienra Monge JJ, Bermejo Guevara MA, del Rio Navarro BE, Rosas Vargas MA, Reyes Ruiz NI. Degree and duration of bronchodilatation after administration of beta 2 agonist alone or in combination with ipratropium bromide in children with acute asthma. Revista Alergia Mexico 2000;47(1):26-9.
82. Silverman M, Tooley M. Oxatomide and exercise-induced asthma in children: the value of serial exercise tests. Clinical Allergy 1981;11(5):421-8.
83. Simone P, Robuschi M, Vaghi A, Fasano W, Bianco S. Prevention of fog-induced bronchospasm by Duovent and its components (fenoterol, ipratropium bromide) in asthmatics. Respiration 1986;50(Suppl 2):192-5.
84. Simonsson BG. Acute effects of ipratropium bromide (ITBR, Sch 1000, Atrovent): a review of previous studies. Scandinavian Journal of Respiratory Diseases 1979;Suppl 103:130-42.
85. Stokes GM, Milner AD, Hodges IG, Henry RL. Nebulised ipratropium bromide in wheezy infants and young children. European Journal of Respiratory Diseases - Supplement 1983;128(Pt 2):494-8.
86. Storms WW, DoPico GA, Reed CE. Aerosol Sch 1000. An anticholinergic bronchodilator. American Review of Respiratory Disease 1975;111(4):419-22.
87. Storms WW, Bodman SF, Nathan RA, Busse WW, Bush RK, Falliers CJ, O'Hollaren JD, Weg JG. Use of ipratropium bromide in asthma. Results of a multi-clinic study. American Journal of Medicine 1986;81(5A):61-6.
88. Storr J, Lenney W. Nebulised ipratropium and salbutamol in asthma. Archives of Disease in Childhood 1986;61(6):602-3.
89. Sur S, Mohiuddin AA, Vichyanond P, Nelson HS. A random double-blind trial of the combination of nebulized atropine methylnitrate and albuterol in nocturnal asthma. Annals of Allergy 1990;65(5):384-8.
90. Svenonius E, Arborelius M Jr, Wiberg R, Ekberg P. Prevention of exercise-induced asthma by drugs inhaled from metered aerosols. Allergy 1988;43(4):252-7.
91. Tasche MJA, Van der Wouden JC, Uijen JHJM, Ponsioen BP, Bernsen RMD, Van Suijlekom-Smit LWA, De Jongste JC. Randomised placebo-controlled trial of inhaled sodium cromoglycate in 1-4 year old children with moderate asthma. Lancet 1997;350(9084):1060-64.
92. Tashkin DP, Katz RM, Kerschnar H, Rachelefsky GS, Siegel SC. Comparison of aerosolized atropine, isoproterenol, atropine plus isoproterenol, disodium cromoglycate and placebo in the prevention of exercise-induced asthma. Annals of Allergy 1977;39(5):311-8.
93. Taytard A, Vergeret J, Guenard H, Vaida P, Bellvert P, Freour P. Prevention of exercise-induced asthma by oxitropium bromide. European Journal of Clinical Pharmacology 1987;33(5):455-8.
94. Thomson NC, Patel KR, Kerr JW. Sodium cromoglycate and ipratropium bromide in exercise-induced asthma. Thorax 1978;33(6):694-9.
95. Tinkelman DG, Cavanaugh MJ. Inhibition of exercise-induced bronchospasm by atropine. American Review of Respiratory Disease 1976;114(1):87-94.
96. Town GI. Comparison between aerosol and powder delivery system of fenoterol plus ipratropium bromide ('Duovent') in patients with asthma and chronic bronchitis. Pharmatherapeutica 1988;5(4):246-8.
97. Tullett WM, Patel KR, Berkin KE, Kerr JW. Effect of lignocaine, sodium cromoglycate, and ipratropium bromide in exercise-induced asthma. Thorax 1982;37(10):737-40.
98. Ulrik CS, Backer V, Bach-Mortensen N. Bronchodilating effect of ipratropium bromide inhalation powder and aerosol in children and adolescents with stable bronchial asthma. Allergy 1992;47(2 Pt 2):133-7.
99. Vichyanond P, Sladek WA, Sur S, Hill MR, Szefler SJ, Nelson HS. Efficacy of atropine methylnitrate alone and in combination with albuterol in children with asthma. Chest 1990;98(3):637-42.
100. Walker FB IV, Kaiser DL, Kowal MB, Suratt PM. Prolonged effect of inhaled glycopyrrolate in asthma. Chest 1987;91(1):49-51.
101. Ward MJ, Fentem PH, Smith WH, Davies D. Ipratropium bromide in acute asthma. British Medical Journal Clinical Research Edition 1981;282(6264):598-600.
102. Ward MJ, Macfarlane JT, Davies D. A place for ipratropium bromide in the treatment of severe acute asthma. British Journal of Diseases of the Chest 1985;79(4):374-8.
103. Watson WTA, Becker AB, Simons FER. Comparison of ipratropium solution, fenoterol solution, and their combination administered by nebulizer and face mask to children with acute asthma. Journal of Allergy and Clinical Immunology 1988;82:1012-8.
104. Watson TA, Shuckett EP, Becker AB, Simons ER. Effect on nebulized ipratropium bromide on intraocular pressures in children. Chest 1994;105:1439-41.
105. Wilson N, Dixon C, Silverman M. Bronchial responsiveness to hyperventilation in children with asthma: inhibition by ipratropium bromide. Thorax 1984;39(8):588-93.
106. Wilson NM, Green S, Coe C, Barnes PJ. Duration of protection by oxitropium bromide against cholinergic challenge. European Journal of Respiratory Diseases 1987;71(5):455-8.
107. Wolkove N, Kreisman H, Frank HG. The effect of ipratropium on exercise-induced bronchospasm. Annals of Allergy 1981;47(5 Pt 1):311-5.
108. Yeung R, Nolan GM, Levison H. Comparison of the effects of inhaled SCH 1000 and fenoterol on exercise-induced bronchospasm in children. Pediatrics 1980;66(1):109-14.
109. Yung M, South M. Randomised controlled trial of aminophylline for severe acute asthma. Archives of Disease in Childhood 1998;79(5):405-10.
110. Zaritsky A, Qureshi F. Ipratropium does indeed reduce admissions to hospital with severe asthma. British Medical Journal 1999;318(7185):738.
111. Zorc JJ, Pusic MV, Ogborn CJ, Lebet R, Duggan AK. Ipratropium bromide added to asthma treatment in the pediatric emergency department. Pediatrics 1999;103(4):748-52.
112. Brophy C, Ahmed B, Bayston S, Arnold A, McGivern D, Greenstone M. How long should atrovent be given in acute asthma?. Thorax 1998;53(5):363-7.
113. British Thoracic Society, British Paediatric Association, Royal College of Physicians of London, National Asthma Campaign. Guidelines on the management of asthma. Thorax 1993;48:S1-24.
114. British Thoracic Society, British Paediatric Association, Royal College of Physicians of London, The King's Fund Centre, National Asthma Campaign. Asthma in adults and schoolchildren. Thorax 1997;52(Suppl 1):S2-S8.
115. British Thoracic Society, British Paediatric Association, Royal College of Physicians of London, The King's Fund Centre, National Asthma Campaign. Asthma in children under five years of age. Thorax 1997;52(Suppl 1):S9-S21.
116. British Thoracic Society, SIGN. British Guideline on the Management of Asthma. Thorax 2003;58(Suppl 1):1-83.
117. Chapman KR. An international perspective on anticholinergic therapy. The American Journal of Medicine 1996;100(Suppl 1a):2s-4s.
118. Doull IJM, Lampe FC, Smith S, Schreiber J, Freezer NJ, Holgate ST. Effect of inhaled corticosteroids on episodes of wheezing associated with viral infection in school age children: randomised double blind placebo controlled trial. BMJ 1997;10(315):858-62.
119. Everard ML, Bara A, Kurian M, Elliott TM, Ducharme F, Mayowe V. Anticholinergics drugs for wheeze in children under the age of two years (Cochrane review). Cochrane Database of Systematic Reviews 2005, Issue 3. [DOI: 10.1002/14651858.CD001279]
120. Goodman, Gilman. Muscarinic Receptor Agonists and Antagonists. In: Hardman JG, Limbard LE editor(s). The Pharmacological Basis of Therapeutics. 9th Edition. McGraw-Hill, 1996:154-9.
121. Gross NJ. Ipratropium Bromide. The New England Journal of Medicine 1988;319(8):486-93.
122. Deeks JJ, Higgins, JPT, Altman DG, editors. Analysing and presenting results. In: Alderson P, Green S, Higgins J, editor(s). Cochrane Reviewers’ Handbook 4.2.2 [updated December 2003]; Section 8, The Cochrane Library. Chichester: John Wiley & Sons Ltd, 2004.
123. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomised controlled trials: is blinding necessary?. Controlled Clinical Trials 1995;143:1-12.
124. Keeley DJ, Silverman M. Are we too ready to diagnose asthma in children?. Thorax 1999;54(7):625-8.
125. Plotnick LH, Ducharme FM. Combined inhaled anticholinergics and beta 2-agonists for initial treatment of acute asthma in children (Cochrane review). Cochrane Database of Systematic Reviews 2000, Issue 2. [DOI: 10.1002/14651858.CD000060]
126. Qureshi F, Zaritsky A, Lakkis H. Efficacy of nebulized ipratropium in severely asthmatic children. Annals of Emergency Medicine 1997;29(2):205-11.
127. Rubin BK, Albers GM. Use of anticholinergic bronchodilatation in children. The American Journal of Medicine 1996;100(Suppl 1a):49s-53s.
128. Serafin W. Drugs used in the treatment of asthma. In: Hardman JG, Limbard LE editor(s). The Pharmacological Basis of Therapeutics. 9th Edition. McGrath-Hill, 1996:659-65.
129. Silverman M, Wilson N. Asthma - time for a change of name?. Archives of Disease in Childhood 1997;77(7):62-5.